Arginine increases insulin-like growth factor-I production and collagen synthesis in osteoblast-like cells.

Protein-energy malnutrition, which is common in elderly patients with osteoporotic hip fractures, is associated with reduced plasma levels of insulin-like growth factor-I (IGF-I). IGF-I is an important regulator of bone metabolism, particularly of osteoblastic bone formation both in vivo and in vitro. Pharmacological doses of arginine (Arg) increase growth hormone (GH) and IGF-I serum levels. Whether amino acids, particularly Arg, can directly modulate the production of IGF-I by osteoblasts is not known. We investigated the effects of increasing concentrations of Arg on IGF-I expression and production, alpha1(I) collagen expression and collagen synthesis, and cell proliferation and cell differentiation, as assessed by alkaline phosphatase (ALP) activity and osteocalcin (OC) release, in confluent mouse osteoblast-like MC3T3-E1 cells. The addition of Arg (7.5-7500 micromol/L, equivalent to 0.1- to 100-fold human plasma concentration) for 48 h increased IGF-I production (adjusted for cell number) in a concentration-dependent manner with a maximum of 2.3 +/- 0.3-fold at 7500 micromol/L Arg [x +/- standard error of the mean (SEM), n = 3 experiments, p < 0.01]. Arg (7.5-7500 micromol/L) increased the percentage of de novo collagen synthesis in a concentration-dependent manner (2.1 +/- 0.4-fold with 7500 micromol/L Arg, p < 0.001) and ALP activity with a maximal stimulation of 144% +/- 13% plateauing at 750 micromol/l Arg (p = 0.002). The steady state level of IGF-I messenger ribonucleic acid (mRNA) and alpha1(I) collagen mRNA (both normalized to cyclophilin mRNA) of cells incubated with Arg at high (100-fold) or low (0.1-fold) human plasma concentrations, was 1.4 +/- 0.2, 1.2 +/- 0.2, and 1.1 +/- 0.2 after 24 h for the 7.5, 1.8, and 0.9 kb IGF-I mRNA transcripts, respectively (n = 3 experiments) and 1.5 +/- 0.2 and 3.1 +/- 0.7 after 24 and 48 h, respectively, for the combined analysis of the 5.6 and 4.7 kb alpha1(I) collagen mRNA transcripts (n = 3 experiments). A maximal mitogenic effect (cell number) of +21% +/- 3% (p < 0.01) was obtained with 1000 micromol/L Arg. In contrast, Arg (7.5-7500 micromol/L) induced a reduction of OC production, which reached 30% +/- 3% with 7500 micromol/L Arg (p = 0.02). In conclusion, Arg stimulated IGF-I production and collagen synthesis in osteoblast-like cells. Thus, Arg may influence bone formation by enhancing local IGF-I production.

[1]  P. Delmas,et al.  Dietary supplementation in elderly patients with fractured neck of the femur , 1990, The Lancet.

[2]  T. Linkhart,et al.  Interleukin‐6 messenger RNA expression and interleukin‐6 protein secretion in cells isolated from normal human bone: Regulation by interleukin‐1 , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  E. Canalis,et al.  Growth factors and cytokines in bone cell metabolism. , 1991, Annual review of medicine.

[4]  D. Rowe,et al.  Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. , 1984, Biochemistry.

[5]  Y. Amagai,et al.  In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria , 1983, The Journal of cell biology.

[6]  E. Canalis,et al.  Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. , 1989, Endocrinology.

[7]  J. V. Van Wyk,et al.  The size heterogeneity of rat insulin-like growth factor-I mRNAs is due primarily to differences in the length of 3'-untranslated sequence. , 1989, Molecular endocrinology.

[8]  A. Barbul,et al.  Arginine stimulates wound healing and immune function in elderly human beings. , 1993, Surgery.

[9]  J. Ketelslegers,et al.  Nutritional regulation of the insulin-like growth factors. , 1994, Endocrine reviews.

[10]  R. Diegelmann,et al.  Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. , 1971, Biochemistry.

[11]  M. Jeevanandam,et al.  Adjuvant recombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients. , 1995, JPEN. Journal of parenteral and enteral nutrition.

[12]  L. Avioli,et al.  Cytokines and bone metabolism , 1993, Calcified Tissue International.

[13]  E. Froesch,et al.  Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. , 1988, Biochemical and biophysical research communications.

[14]  M. Nicolosi,et al.  Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration , 1994, Journal of endocrinological investigation.

[15]  D. Thiebaud,et al.  Regulation of collagen type I and biglycan mRNA levels by hormones and growth factors in normal and immortalized osteoblastic cell lines , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  V. Shih Regulation of ornithine metabolism. , 1981, Enzyme.

[17]  A. Pegg,et al.  Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. , 1988, Cancer research.

[18]  S. Ljunghall,et al.  Low plasma levels of insulin‐like growth factor 1 (IGF‐1) in male patients with idiopathic osteoporosis , 1992, Journal of internal medicine.

[19]  S. Mohan,et al.  Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging. , 1994, The Journal of clinical endocrinology and metabolism.

[20]  J. Sutcliffe,et al.  p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. , 1988, DNA.

[21]  L. Phillips,et al.  Nutrition and Somatomedin: XXIII. Molecular Regulation of IGF-I by Amino Acid Availability in Cultured Hepatocytes , 1991, Diabetes.

[22]  L. Raisz,et al.  Local and systemic factors in the pathogenesis of osteoporosis. , 1988, World review of nutrition and dietetics.

[23]  S. Allison,et al.  Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial. , 1983, British medical journal.

[24]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[25]  R. Rizzoli,et al.  IGF-I and pamidronate increase bone mineral density in ovariectomized adult rats. , 1993, The American journal of physiology.

[26]  A. Isidori,et al.  A study of growth hormone release in man after oral administration of amino acids. , 1981, Current medical research and opinion.

[27]  P. Gluckman,et al.  Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. , 1991, The Journal of endocrinology.

[28]  M. Ranke,et al.  Decreased serum levels of insulin‐like growth factors and IGF binding protein 3 in osteoporosis , 1993, Journal of internal medicine.

[29]  R. Rizzoli,et al.  Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. , 1992, Journal of the American College of Nutrition.

[30]  J. E. Hepler,et al.  Structural characterization of exon 6 of the rat IGF-I gene. , 1992, DNA and cell biology.

[31]  R. Rizzoli,et al.  Protein Supplements Increase Serum Insulin-Like Growth Factor-I Levels and Attenuate Proximal Femur Bone Loss in Patients with Recent Hip Fracture , 1998, Annals of Internal Medicine.

[32]  T. Suda,et al.  Transforming growth factor-beta modulates proliferation and differentiation of mouse clonal osteoblastic MC3T3-E1 cells depending on their maturation stages. , 1990, Bone and mineral.

[33]  J. Morley,et al.  Malnutrition in the elderly. , 1992, Hospital practice.

[34]  L. Quarles,et al.  Differentiation of MC3T3-E1 osteoblasts is associated with temporal changes in the expression of IGF-I and IGFBPs. , 1995, Bone.

[35]  E. Canalis,et al.  Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. , 1989, Endocrinology.

[36]  R. Bouillon,et al.  Influence of vitamin D on parathyroid function in the elderly. , 1992, The Journal of clinical endocrinology and metabolism.

[37]  P. Nibbering,et al.  Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. , 1994, The Journal of clinical investigation.

[38]  E. Canalis,et al.  Growth factors regulate the synthesis of insulin-like growth factor-I in bone cell cultures. , 1993, Endocrinology.

[39]  A. Barbul,et al.  Metabolic effects of arginine in a healthy elderly population. , 1995, JPEN. Journal of parenteral and enteral nutrition.

[40]  J. Ketelslegers,et al.  The decreased plasma concentration of insulin-like growth factor-I in protein-restricted rats is not due to decreased numbers of growth hormone receptors on isolated hepatocytes. , 1990, The Journal of endocrinology.

[41]  M. Hammerman,et al.  Insulin-like growth factors and aging. , 1987, Endocrinology and metabolism clinics of North America.

[42]  D. Straus,et al.  Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver. , 1990, Molecular endocrinology.

[43]  Subburaman Mohan,et al.  Growth factors to stimulate bone formation , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  J. Riancho,et al.  Expression and functional role of nitric oxide synthase in osteoblast‐like cells , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  E. Ruoslahti,et al.  L-arginine may mediate the therapeutic effects of low protein diets. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Mohan,et al.  Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. , 1989, Endocrinology.

[47]  D. Le Roith,et al.  Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. , 1997 .

[48]  G. Stein,et al.  The onset and progression of osteoblast differentiation is functionally related to cellular proliferation. , 1989, Connective tissue research.

[49]  S. Ralston,et al.  Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. , 1994, Endocrinology.